Monday, September 14, 2026

Is the Yoon Administration’s Response to North Korea’s Drone Threat Adequate? A Deep Dive

Tensions rise as ruling and opposition parties clash over North Korea's drone claims, with calls for clarity on national security responses.

Kia Hits a Major Milestone: 2 Million Cars Rolled Out from Mexico

Kia Mexico announced today that it has shipped its 2 millionth vehicle, achieving this milestone in just 8 years and 3 months.

How North Korea Plans to Tackle Monsoon Risks: Insights from the Latest Party Meeting

North Korea emphasizes industrial production and disaster preparedness as monsoon season approaches, while promoting socialist patriotism.

Tag: cancer

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Yuhan’s Leclaza Wins Best Pharmaceutical Product at Asia’s First Prix Galien Awards

Yuhan Corporation's lung cancer drug 'Lecanza' wins Best Pharmaceutical Product at the inaugural 'Prix Galien' in Asia.

Unlocking Cancer Treatment: How Lunit and 10x Genomics Are Pioneering New Biomarkers for Precision Medicine

Lunit partners with 10x Genomics to discover biomarkers predicting cancer drug effectiveness in patients.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

How COLO eDX is Changing Colon Cancer Monitoring: Key Insights from iCRS 2026

Gencurix confirms its blood-based colon cancer test can detect cancer and monitor recurrence post-surgery.

Why Quitting Smoking After Cancer Diagnosis is Crucial: Study Reveals 36% Lower Heart Disease Risk

A study shows cancer patients who continue smoking face higher risks of cardiovascular disease and death compared to those who quit.

Curocell’s ‘Lymcato’ Clears Review for National Health Insurance Coverage

Curocell’s CAR-T therapy Lymcato has passed the Health Insurance Review and Assessment Service’s drug reimbursement review, accelerating its path toward national health insurance coverage this year.

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

Samsung Seoul Hospital Performs 1 in 5 Gastric Cancer Surgeries With Robots

Samsung Seoul Hospital has performed 1,500 cumulative robotic gastric cancer surgeries, with robot-assisted procedures accounting for 22% of all gastric cancer surgeries last year.

Revolutionary Liver Cancer Treatment: How Rivoceranib + Camrelizumab Outperforms Sorafenib in Young Patients

HLB's liver cancer drug combo shows consistent efficacy across all age groups.

GC Biopharma Leads Innovation in Cancer Treatment with AI-Powered mRNA Platform

Moderna's recent success in personalized cancer vaccine trials highlights the growing interest in mRNA technology.

200 Successful Treatments: How Lu-177 PSMA Therapy is Revolutionizing Prostate Cancer Care in South Korea

The Catholic University Seoul St. Mary's Hospital's Urology Cancer Center achieves 200 cumulative treatments for metastatic prostate cancer.

AbClon Secures Japanese Patent for Dual-Antibody Cancer Drug AM105: What This Means for Global Markets

AbClon has completed the registration of a Japanese patent for its next-generation dual antibody immuno-oncology candidate AM105.

CS5001 Breakthrough: 100% Complete Remission in DLBCL Trials – What This Means for Cancer Treatment

ABL Bio's ADC candidate shows complete response in all patients in early trials for first-line treatment of DLBCL.

SOT106: The Groundbreaking ADC Cancer Drug Fast-Tracked by FDA for Soft Tissue Sarcoma

LigaChem Biosciences' antibody-drug conjugate (ADC) cancer treatment candidate has received Fast Track designation from the FDA.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.